Latest Trustworthy News from Dr. Mercola - delivered straight to your inbox!

The FDA's New Vaccine Strategy

Analysis by Dr. Joseph Mercola Fact Checked

Story at-a-glance

  • When the bivalent COVID boosters against Omicron first came out, only those who had received the initial series of shots were eligible to receive them, but uptake was disappointing. Less than 5% of those eligible had taken a bivalent booster by October 2022, and by late January 2023, that had only risen to 16.2%


By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Service.